Results
Sandu Pharmaceuticals FY26 Net Profit Up 23.2% with Board Changes
Sandu Pharmaceuticals reported FY26 revenue of ₹69.93 crore and net profit growth of 23.2% with a recommended dividend of ₹1 per share.
The company announced board changes including Balram Viswanathan
